Spain Bioinformatics Market Analysis Report [2022-30] I Insights10

Spain Bioinformatics Market Analysis

$ 3999

The Spain Bioinformatics market is projected to grow from $296.26 Mn in 2022 to $925.34 Mn by 2030, registering a CAGR of 15.30% during the forecast period of 2022 - 2030. The main factors driving the growth would be increasing investments, government support, and high digital adoption. The market is segmented by technology and by application. Some of the major players include Sequentia Biotech SL (ESP), Anaxomics Biotech (ESP), ESTEVE (ESP), Mind the Byte (ESP), and Agilent Technologies.

ID: IN10ESHS001 CATEGORY: Healthcare Services GEOGRAPHY: Spain AUTHOR: Neha Davda

Buy Now

Spain Bioinformatics Market Executive Summary

The Spain Bioinformatics market is projected to grow from $296.26 Mn in 2022 to $925.34 Mn by 2030, registering a CAGR of 15.30% during the forecast period of 2022 - 2030. In 2019, healthcare spending increased from $2,711 per person, or 9.13% of its GDP from $2,740 per person, or 8.99% of GDP in 2018. The per capita health expenditure in Spain remains lower than the EU average. In terms of total health spending, there is a widening disparity between Spain and the EU which indicates slower growth over the last decade.

The field of bioinformatics is an interdisciplinary combination of biology and IT. Bioinformatics uses a variety of approaches, including data production, data warehousing, data mining, data management, and more. In order to provide statistical methodologies and data processing algorithms for applications like next-generation sequencing, modeling of genomic and proteomic structure, and three-dimensional drug discovery, bioinformatics software and tools are employed as integrated solutions. In Spain, the bioinformatics market is rapidly growing and has a convincing presence in the global market. This can be seen in the numerous bioinformatics companies and research facilities in Spain.

Spain bioinformatics market analysis

Market Dynamics

Market Growth Drivers

The Spain bioinformatics market is attracting sizable investments from venture capitalists and private equity firms, which is anticipated to fuel the market's expansion. The government of Spain has also made substantial investments in developing infrastructure and resources for bioinformatics such as the National Bioinformatics Institute (INB) and the Spanish National Genotyping Center (CNAG-CRG). Moreover, in 2020, Spain ranked 11^th on the Digital Economy and Society Index (DESI) of EU-28 and achieved the fourth biggest increase in the last five years. This high adoption will further drive growth in the bioinformatics market.

Market Restraints

The factors that are limiting the growth of the market are a lack of standardization in the bioinformatics field, limited funding for research and development for innovations, and limited awareness about the potential benefits of bioinformatics among professionals.

Competitive Landscape

Key Players

Sequentia Biotech SL (ESP)
Anaxomics Biotech (ESP)
ESTEVE (ESP)
Mind the Byte (ESP)
Agilent Technologies

Healthcare Policies and Regulatory Landscape

The Spain healthcare system is managed by both the national government and the regional governments with the national government being in charge of general policy-making and regulation. Primary care, secondary care, and tertiary care are the three tiers of the Spanish healthcare system.

Spanish medical products, including those related to bioinformatics, are governed by the Spanish Agency for Medicines and Health Products (AEMPS). The AEMPS must approve medical items in Spain before they can be marketed. Spain has adopted the General Data Protection Regulation (GDPR) for the security and privacy of data. The GDPR imposes strict standards for data security and privacy and imposes severe fines for violations.

Reimbursement Scenario

Spain has a national healthcare system that provides universal coverage. The system is run by regional governments, and it is financed by a combination of public funding and social security contributions. Regional governments in Spain decide on reimbursement rules for the bioinformatics industry, and these regulations can change from area to region.

In general, the Spanish National Health System (SNHS) decides how much to reimburse for bioinformatics goods and services in Spain. Before an item is added to the national reimbursement list, the SNHS assesses its financial and medical benefits. The presence of a good or service on the reimbursement list is then used to calculate the reimbursement rate.

1. Executive Summary
1.1 Service Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Healthcare Services Market in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Services
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Bioinformatics Market Segmentation

By Technology (Revenue, USD Billion):

Knowledge Management Tools
Bioinformatics Platforms
Bioinformatics Services

By Application (Revenue, USD Billion):

Metabolomics
Molecular phylogenetics
Transcriptomics
Chemoinformatic & drug design
Genomics
Others

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.